Skip to content

Lucas Serra, MD

NPI 1558936088ActiveIndividual· Radiology, Radiation Oncology· Pittsburgh, PA

Radiology, Radiation Oncology (MD) in Pittsburgh, Pennsylvania, licensed in PA, with an NPI issued in May 2021. Part D covered 21 prescriptions written in 2024, 100% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 2 companies reporting payments in 2025, $174.75 in all, mostly food and beverage.

Overview

NPI1558936088
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMay 26, 2021
Last updated in NPPESOct 2, 2026
Certified by providerOct 2, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Radiology, Radiation Oncology Primary2085R0001XMD496073PA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Radiation Oncology (PA)

Part D prescriptions in 2024

Prescriptions (claims)21 · 23 30-day fills
Patients14
Total drug cost$314.32
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$174.75 · 2 payments from 2 companies
  • 2024$383.56 · 7 payments from 3 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$174.75 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Radiology, Radiation Oncology providers in Pittsburgh

All Radiology, Radiation Oncology providers in Pennsylvania →